Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
530.00 GBX | +0.38% |
|
-2.57% | -18.40% |
05-28 | RBC cuts National Grid; Citigroup cuts South32 | AN |
05-27 | Barclays Trims Tate & Lyle PT, Affirms Overweight Rating | MT |
Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.81B | 1.38B | 1.75B | 1.65B | 1.74B | |||||
Total Revenues | 2.81B | 1.38B | 1.75B | 1.65B | 1.74B | |||||
Cost of Goods Sold, Total | 1.66B | 696M | 876M | 796M | 825M | |||||
Gross Profit | 1.14B | 679M | 875M | 851M | 911M | |||||
Selling General & Admin Expenses, Total | 182M | 263M | 287M | 265M | 321M | |||||
Provision for Bad Debts | -2M | - | - | - | - | |||||
R&D Expenses | 43M | - | - | - | - | |||||
Depreciation & Amortization - (IS) | 142M | 56M | 59M | 58M | 86M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 33M | 24M | 36M | 36M | 42M | |||||
Other Operating Expenses | 412M | 173M | 270M | 261M | 211M | |||||
Other Operating Expenses, Total | 810M | 516M | 652M | 620M | 660M | |||||
Operating Income | 332M | 163M | 223M | 231M | 251M | |||||
Interest Expense, Total | -26M | -23M | -29M | -22M | -35M | |||||
Interest And Investment Income | 1M | 1M | 12M | 19M | 20M | |||||
Net Interest Expenses | -25M | -22M | -17M | -3M | -15M | |||||
Income (Loss) On Equity Invest. | 26M | - | -24M | 25M | - | |||||
Currency Exchange Gains (Loss) | - | -2M | -1M | - | -1M | |||||
Other Non Operating Income (Expenses) | - | - | - | - | -14M | |||||
EBT, Excl. Unusual Items | 333M | 139M | 181M | 253M | 221M | |||||
Restructuring Charges | -20M | -1M | -5M | -21M | -72M | |||||
Merger & Related Restructuring Charges | - | - | - | -2M | -80M | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Asset Writedown | -8M | -17M | -1M | -1M | - | |||||
Insurance Settlements | 2M | - | - | - | - | |||||
Legal Settlements | -5M | - | 3M | - | - | |||||
Other Unusual Items | -19M | -79M | -26M | -3M | 19M | |||||
EBT, Incl. Unusual Items | 283M | 42M | 152M | 226M | 88M | |||||
Income Tax Expense | 30M | 16M | 25M | 47M | 43M | |||||
Earnings From Continuing Operations | 253M | 26M | 127M | 179M | 45M | |||||
Earnings Of Discontinued Operations | - | 210M | 63M | 9M | 95M | |||||
Net Income to Company | 253M | 236M | 190M | 188M | 140M | |||||
Minority Interest | - | - | - | - | 3M | |||||
Net Income - (IS) | 253M | 236M | 190M | 188M | 143M | |||||
Net Income to Common Incl Extra Items | 253M | 236M | 190M | 188M | 143M | |||||
Net Income to Common Excl. Extra Items | 253M | 26M | 127M | 179M | 48M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.64 | 0.59 | 0.47 | 0.47 | 0.35 | |||||
Basic EPS - Continuing Operations | 0.64 | 0.07 | 0.31 | 0.45 | 0.12 | |||||
Basic Weighted Average Shares Outstanding | 398M | 399M | 404M | 397M | 409M | |||||
Net EPS - Diluted | 0.63 | 0.59 | 0.46 | 0.47 | 0.34 | |||||
Diluted EPS - Continuing Operations | 0.63 | 0.06 | 0.31 | 0.44 | 0.12 | |||||
Diluted Weighted Average Shares Outstanding | 402M | 403M | 411M | 404M | 415M | |||||
Normalized Basic EPS | 0.52 | 0.22 | 0.28 | 0.4 | 0.34 | |||||
Normalized Diluted EPS | 0.52 | 0.22 | 0.27 | 0.39 | 0.34 | |||||
Dividend Per Share | 0.36 | 0.22 | 0.18 | 0.19 | 0.2 | |||||
Payout Ratio | 54.15 | 61.02 | 38.42 | 40.43 | 55.94 | |||||
American Depositary Receipts Ratio (ADR) | 4 | 4 | 4 | 4 | 4 | |||||
Supplemental Items | ||||||||||
EBITDA | 478M | 250M | 296M | 303M | 356M | |||||
EBITA | 365M | 189M | 246M | 254M | 280M | |||||
EBIT | 332M | 163M | 223M | 231M | 251M | |||||
EBITDAR | 479M | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 10.6 | 38.1 | 16.45 | 20.8 | 48.86 | |||||
Current Domestic Taxes | - | - | - | - | - | |||||
Current Foreign Taxes | - | - | - | - | - | |||||
Total Current Taxes | 48M | 36M | 45M | 71M | 36M | |||||
Total Deferred Taxes | -18M | -20M | -20M | -24M | 7M | |||||
Normalized Net Income | 208M | 86.88M | 113M | 158M | 141M | |||||
Interest on Long-Term Debt | 6M | 2M | 2M | 2M | 2M | |||||
Non-Cash Pension Expense | 7M | -8M | 5M | 3M | 5M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 43M | 41M | 46M | 44M | 50M | |||||
Net Rental Expense, Total | 1M | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | 275K | - | - | - | - | |||||
Imputed Operating Lease Depreciation | 725K | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 8M | 12M | 20M | 13M | 12M | |||||
Total Stock-Based Compensation | 8M | 12M | 20M | 13M | 12M |
- Stock Market
- Equities
- TATE Stock
- Financials Tate & Lyle plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition